Tanner Pharma
Tanner Pharma Group, commonly referred to as Tanner Pharma, is a leading provider of global access solutions for patients in need of critical medications. Headquartered in the United States, the company operates extensively across North America, Europe, and Asia, focusing on the pharmaceutical industry. Founded in 2008, Tanner Pharma has achieved significant milestones, including the development of innovative programmes that facilitate access to life-saving therapies. The company specialises in providing comprehensive services such as patient access programmes, clinical trial support, and supply chain management. What sets Tanner Pharma apart is its commitment to ensuring that patients receive the medications they require, regardless of geographical or financial barriers. With a strong market position and a reputation for excellence, Tanner Pharma continues to make a meaningful impact in the healthcare landscape.
DitchCarbon Score
How does Tanner Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tanner Pharma's score of 23 is lower than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tanner Pharma's reported carbon emissions
Tanner Pharma, headquartered in the US, currently does not have publicly available carbon emissions data for recent years. As a result, specific figures regarding their emissions in kg CO2e, including Scope 1, 2, or 3 emissions, are not provided. In the absence of detailed emissions data, it is important to note that Tanner Pharma has not outlined any specific reduction targets or initiatives related to carbon emissions. This lack of information suggests that the company may still be in the early stages of developing a comprehensive climate strategy or may not have publicly committed to industry-standard climate pledges. As the global focus on sustainability intensifies, it is crucial for companies like Tanner Pharma to establish clear climate commitments and reduction targets to align with industry best practices and contribute to broader climate goals.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tanner Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
